BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18180878)

  • 1. The selectin-selectin ligand axis in tumor progression.
    Witz IP
    Cancer Metastasis Rev; 2008 Mar; 27(1):19-30. PubMed ID: 18180878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-microenvironment interactions: the selectin-selectin ligand axis in tumor-endothelium cross talk.
    Witz IP
    Cancer Treat Res; 2006; 130():125-40. PubMed ID: 16610706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of selectins and their ligands in tumor-progression.
    Witz IP
    Immunol Lett; 2006 Apr; 104(1-2):89-93. PubMed ID: 16368149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectins promote tumor metastasis.
    Läubli H; Borsig L
    Semin Cancer Biol; 2010 Jun; 20(3):169-77. PubMed ID: 20452433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-selectin mediates metastatic progression through binding to sulfatides on tumor cells.
    Garcia J; Callewaert N; Borsig L
    Glycobiology; 2007 Feb; 17(2):185-96. PubMed ID: 17043066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectins and glycosyltransferases in leukocyte rolling in vivo.
    Sperandio M
    FEBS J; 2006 Oct; 273(19):4377-89. PubMed ID: 16956372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selectins as adhesion molecules and potential therapeutic target].
    Jebali J; Jeanneau C; Bazaa A; Mathieu S; El Ayeb M; Luis J; El Battari A; Marrakchi N
    Arch Inst Pasteur Tunis; 2011; 88(1-4):3-18. PubMed ID: 23461138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned from clustering of fluorinated glycolipids on selectin ligand function in cell rolling.
    Schumacher G; Bakowsky U; Gege C; Schmidt RR; Rothe U; Bendas G
    Biochemistry; 2006 Mar; 45(9):2894-903. PubMed ID: 16503644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of the sLe-a selectin ligand in the extravasation of human colorectal carcinoma cells.
    Ben-David T; Sagi-Assif O; Meshel T; Lifshitz V; Yron I; Witz IP
    Immunol Lett; 2008 Mar; 116(2):218-24. PubMed ID: 18191232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectins--potential pharmacological targets?
    Kneuer C; Ehrhardt C; Radomski MW; Bakowsky U
    Drug Discov Today; 2006 Nov; 11(21-22):1034-40. PubMed ID: 17055414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics.
    Thomas SN; Tong Z; Stebe KJ; Konstantopoulos K
    Biorheology; 2009; 46(3):207-25. PubMed ID: 19581728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectins: critical mediators of leukocyte recruitment.
    Patel KD; Cuvelier SL; Wiehler S
    Semin Immunol; 2002 Apr; 14(2):73-81. PubMed ID: 11978079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases.
    van Gils JM; Zwaginga JJ; Hordijk PL
    J Leukoc Biol; 2009 Feb; 85(2):195-204. PubMed ID: 18948548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest.
    Läubli H; Stevenson JL; Varki A; Varki NM; Borsig L
    Cancer Res; 2006 Feb; 66(3):1536-42. PubMed ID: 16452210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectins-an emerging target for drug delivery.
    Ehrhardt C; Kneuer C; Bakowsky U
    Adv Drug Deliv Rev; 2004 Mar; 56(4):527-49. PubMed ID: 14969757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cells in transit: the vascular interactions of tumor cells.
    Konstantopoulos K; Thomas SN
    Annu Rev Biomed Eng; 2009; 11():177-202. PubMed ID: 19413512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectin inhibitors: a patent review.
    Bedard PW; Kaila N
    Expert Opin Ther Pat; 2010 Jun; 20(6):781-93. PubMed ID: 20408735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans.
    Varki NM; Varki A
    Semin Thromb Hemost; 2002 Feb; 28(1):53-66. PubMed ID: 11885026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection of antisense core 2 beta1,6-N-acetylglucosaminyltransferase-1 cDNA suppresses selectin ligand expression and tissue infiltration of B-cell precursor leukemia cells.
    Kikuchi J; Ozaki H; Nonomura C; Shinohara H; Iguchi S; Nojiri H; Hamada H; Kiuchi A; Nakamura M
    Leukemia; 2005 Nov; 19(11):1934-40. PubMed ID: 16179912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors involved in microenvironment-driven molecular evolution of cancer cells.
    Eshel R; Neumark E; Sagi-Assif O; Witz IP
    Semin Cancer Biol; 2002 Apr; 12(2):139-47. PubMed ID: 12027586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.